Inst Diagnosti (INDISA) — Working Capital to Net Assets Ratio
Inst Diagnosti (INDISA) has a Working Capital to Net Assets ratio of -0.3% as of June 2025. Working capital of CL$-327.44 Million (current assets of CL$99.22 Billion minus current liabilities of CL$99.55 Billion) is measured against net assets of CL$114.04 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Inst Diagnosti (INDISA) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Inst Diagnosti Working Capital to Net Assets (2014–2025)
This chart shows how Inst Diagnosti's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2025, the ratio stands at -0.3%, reflecting working capital of CL$-327.44 Million against net assets of CL$114.04 Billion CLP. Check INDISA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Inst Diagnosti (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Inst Diagnosti from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Inst Diagnosti.
| Year | WC/NA Ratio | Working Capital (CLP) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 8.2% | CL$16.96 Billion | CL$207.27 Billion | CL$111.94 Billion | CL$94.97 Billion | ▼ -6.0 pp |
| 2024 | 14.2% | CL$15.49 Billion | CL$109.16 Billion | CL$98.84 Billion | CL$83.35 Billion | ▲ +3.7 pp |
| 2023 | 10.5% | CL$10.89 Billion | CL$104.02 Billion | CL$99.63 Billion | CL$88.74 Billion | ▼ -0.2 pp |
| 2022 | 10.7% | CL$10.90 Billion | CL$101.70 Billion | CL$99.25 Billion | CL$88.36 Billion | ▲ +20.9 pp |
| 2021 | -10.2% | CL$-9.67 Billion | CL$95.17 Billion | CL$86.22 Billion | CL$95.89 Billion | ▼ -24.9 pp |
| 2020 | 14.7% | CL$12.49 Billion | CL$84.82 Billion | CL$71.36 Billion | CL$58.87 Billion | ▼ -12.4 pp |
| 2019 | 27.2% | CL$22.25 Billion | CL$81.92 Billion | CL$66.90 Billion | CL$44.66 Billion | ▼ -4.2 pp |
| 2018 | 31.4% | CL$23.89 Billion | CL$76.08 Billion | CL$65.28 Billion | CL$41.39 Billion | ▲ +1.1 pp |
| 2017 | 30.3% | CL$20.92 Billion | CL$69.00 Billion | CL$64.49 Billion | CL$43.57 Billion | ▼ -8.0 pp |
| 2016 | 38.3% | CL$24.14 Billion | CL$63.05 Billion | CL$65.10 Billion | CL$40.96 Billion | ▲ +12.1 pp |
| 2015 | 26.1% | CL$14.83 Billion | CL$56.73 Billion | CL$56.33 Billion | CL$41.50 Billion | ▲ +4.7 pp |
| 2014 | 21.5% | CL$10.76 Billion | CL$50.16 Billion | CL$42.02 Billion | CL$31.25 Billion | — |